Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes [NA]
The clinical trial evaluating glycated albumin as an intervention to improve glycemic control in Chinese patients with Type 2 Diabetes has c…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes [Phase 1]
A Phase 1 study assessing how faster-acting insulin aspart works in Chinese people with Type 1 or Type 2 diabetes has completed.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk
A completed clinical trial investigates whether genomics can estimate the risk of diabetic ketoacidosis in people with type 2 diabetes treat…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Validity And Reliability of The Incremental Shuttle Walk Test In Type 2 Diabetes Mellitus
This clinical trial update reports on the validity and reliability of the Incremental Shuttle Walk Test in people with Type 2 Diabetes Melli…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Helping Couples Communicate Better: Does This Help Persons With Type 2 Diabetes Respond Better to a Step Count Prescription? [NA]
A clinical trial update on a study to see if involving partners helps adults with Type 2 diabetes respond to a step-count prescription; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Type 2 Diabetes and Associated Factors in Mexico
A clinical trial investigating Type 2 diabetes and associated factors in Mexico is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management [NA]
Clinical trial update describing an integrated traditional Chinese medicine and Western medicine strategy, including telemedicine, for long-…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabetes [NA]
The document reports a clinical trial evaluating artificial intelligence–based methods to predict disease progression in youth with Type 2 d…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community [NA]
This clinical trial update notes that enrollment is ongoing by invitation for a study evaluating adaptive cognitive training to improve cogn…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
This clinical trial aims to subclass mental health conditions within diabetes using digital twins to enable precision mental health tracking…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Type 2 Diabetes Secondary Prevention
Clinical trial NCT01207349 investigating secondary prevention in Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM [NA]
This completed clinical trial assessed the safety and efficacy of a fixed-ratio insulin degludec/insulin aspart regimen in adults with type …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access [NA]
A Yale-sponsored clinical trial is recruiting to study the impact of expanding access to continuous glucose monitors for people with type 2 …
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Triglyceride-Glucose and TGI-BMI Indices Compared With HOMA-IR
The trial update compares triglyceride-glucose (TyG) and TyG-BMI indices with HOMA-IR for assessing insulin resistance in participants with …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II [Phase 1]
A Phase 1 clinical trial is evaluating the pharmacokinetics and pharmacodynamics of daily enteric-coated aspirin in adults with stable type …
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Foot-Ankle Exercise and Walking Exercise on Diabetes Mellitus Patients [NA]
A completed clinical trial evaluating the effects of foot-ankle and walking exercises in patients with Type 2 diabetes. The study included i…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Effect of Diabetic Foot Exercises on Peripheral Vascular Status in Type 2 Diabetes Mellitus Patients [NA]
Completed clinical trial evaluating whether diabetic foot exercises improve peripheral vascular status in people with type 2 diabetes. The s…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3) [Phase 3]
A Phase 3 trial comparing a once-weekly combination therapy IcoSema (insulin icodec + semaglutide) to daily insulin glargine with insulin as…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9) [Phase 3]
This Clinical Trial Update reports the completion of ONWARDS 9, a Phase 3 study evaluating once-weekly insulin icodec in insulin-naïve adult…
-
FDA approval · 2025-12-02FDA Approved: SITAGLIPTIN AND METFORMIN HYDROCHLORIDE — Original Application (Sandoz Inc)
FDA approved a generic sitagliptin and metformin hydrochloride tablet from Sandoz in an Original Application (ANDA 202388).
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Lactate and Glycerol Contribution to Gluconeogenesis [NA]
A Rutgers-led clinical trial assesses how lactate and glycerol contribute to gluconeogenesis in people with Type 2 diabetes mellitus and obe…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Post Prandial Individual Responses to Different Foods [NA]
A Stanford University clinical trial studying postprandial responses to different foods across people with prediabetes, type 2 diabetes, and…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Prevalence of NAFLD in T2DM Patients [NA]
This clinical trial update notes an observational study on the prevalence of nonalcoholic fatty liver disease in patients with type 2 diabet…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Biological Sample Repository for Gastrointestinal Disorders
This document provides a clinical trial update about a biological sample repository for gastrointestinal disorders. It outlines ongoing acti…
-
EMA approval · 2025-12-01EMA Authorised: Efficib (sitagliptin;metformin hydrochloride) — Merck Sharp and Dohme B.V
EMA authorised Efficib, a fixed-dose combination tablet of sitagliptin and metformin for type 2 diabetes mellitus; Merck Sharp & Dohme B.V. …